1. Assessing the impact of COVID-19 on the management of patients with liver diseases: A national survey by the Italian association for the study of the Liver.
- Author
-
Aghemo A, Masarone M, Montagnese S, Petta S, Ponziani FR, and Russo FP
- Subjects
- Antiviral Agents therapeutic use, Betacoronavirus, COVID-19, Carcinoma, Hepatocellular therapy, Chronic Disease, Esophageal and Gastric Varices diagnosis, Esophageal and Gastric Varices surgery, Hepatitis B, Chronic drug therapy, Hepatitis C, Chronic drug therapy, Humans, Italy epidemiology, Liver Cirrhosis therapy, Liver Neoplasms therapy, Liver Transplantation statistics & numerical data, Mass Screening, Pandemics, Paracentesis statistics & numerical data, Quality of Health Care, SARS-CoV-2, Surveys and Questionnaires, Ambulatory Care statistics & numerical data, Coronavirus Infections epidemiology, Gastroenterology statistics & numerical data, Hospitalization statistics & numerical data, Liver Diseases therapy, Pneumonia, Viral epidemiology
- Abstract
Background: The COVID-19 pandemic had a huge impact on national and regional health systems. The impact of SARS-CoV-2 on the quality of care for patients with liver disease is still unknown., Aims: The Italian Association for the Study of the Liver (AISF) conducted a survey to assess the impact of SARS-CoV-2 on hepatology units activities in Italy., Methods: A prospective web-based survey was proposed to all AISF active members. The survey was available online from April 8 2020, to May 3 2020, (lockdown phase in Italy)., Results: 194 AISF members answered the questionnaire, most of whom were specialists in Gastroenterology (41%) or Internal Medicine (28%), and worked in Northern Italy (51%). 26% of hepatology wards had been converted into COVID-19 wards, and 33% had bed reductions. All hepatological activities, including the management of patients with decompensated liver disease, liver transplant and HCC had been significantly reduced/stopped. The number of physicians answering that their practices had not been modified ranged between 0.6% (for chronic hepatitis) to 47% (for the execution of paracentesis). The recorded answers were consistent among different regions, and did not show any north-south gradient CONCLUSION: COVID-19 outbreak significantly impacted on hepatological clinical activity. This survey can serve as a basis to compare the impact of future measures aimed at delivering an acceptable level of liver care during a national pandemic or crisis., Competing Interests: Declaration of Competing Interest All Authors report no relevant conflicts of interests, (Copyright © 2020 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF